Department of Oral and Maxillofacial Surgery, Côte de Nacre University Hospital, 14 000, Caen Cedex, France.
Department of Oral and Maxillofacial Surgery, Côte de Nacre University Hospital, 14 000, Caen Cedex, France.
J Craniomaxillofac Surg. 2020 Apr;48(4):399-404. doi: 10.1016/j.jcms.2020.02.012. Epub 2020 Feb 24.
The purpose of our study was to evaluate the benefit of bilateral inferior alveolar nerve block (BIANB) in managing postoperative pain, nausea and vomiting and opioid and antiemetic consumption in mandibular osteotomy.
51 patients operated for bilateral sagittal split osteotomy (BSSO) were included in this prospective randomized controlled, double-blind, superiority trial. In the first group (n = 25), standard protocol was applied (general anesthesia and postoperative multimodal analgesia). The second group (n = 26) received bilateral inferior alveolar nerve block anesthesia at the start of surgery in addition to routine protocol. Postoperative monitoring was conducted every 4 h over the first 24 h and targeted the following criteria: postoperative nausea and vomiting (PONV), the visual analog scale (VAS) for pain, consumption of morphine (cumulative dose) and antiemetic agents, need for removal of guiding elastics.
PONV was significantly lower in the BIANB group (15.4 % VS 40 %, p = 0.049), as were mean VAS scores for pain (1 VS 1.57, p = 0.045) and medians of morphine bolus (8 [6-16] VS 5.5 [1-8], p = 0.033). We found no significant difference in incidence of guiding elastic removal, and antiemetic consumption.
The use of BIANB in BSSO improved postoperative patient comfort in terms of PONV and pain. Furthermore, it led to a decrease in opioid consumption. In conclusion, it is an additional therapeutic means of improving patients' postoperative comfort.
我们研究的目的是评估双侧下牙槽神经阻滞(BIANB)在管理下颌骨切开术后疼痛、恶心和呕吐以及阿片类药物和止吐药的消耗方面的益处。
本前瞻性随机对照、双盲、优效性试验纳入了 51 例双侧矢状劈开截骨术(BSSO)患者。在第一组(n=25)中,应用了标准方案(全身麻醉和术后多模式镇痛)。第二组(n=26)在手术开始时接受双侧下牙槽神经阻滞麻醉,外加常规方案。术后监测在最初 24 小时内每 4 小时进行一次,监测以下标准:术后恶心和呕吐(PONV)、视觉模拟评分(VAS)疼痛评分、吗啡(累积剂量)和止吐药的消耗、需要去除引导弹性。
BIANB 组的 PONV 明显较低(15.4%VS40%,p=0.049),疼痛 VAS 评分(1 VS1.57,p=0.045)和吗啡推注中位数(8[6-16]VS5.5[1-8],p=0.033)也较低。我们发现引导弹性去除和止吐药消耗的发生率无显著差异。
BSSO 中使用 BIANB 可改善术后患者 PONV 和疼痛的舒适度。此外,它还导致阿片类药物消耗减少。总之,它是一种额外的治疗手段,可以提高患者术后的舒适度。